ZNF280B promotes the growth of gastric cancer in vitro and in vivo.

Zinc finger protein 280B (ZNF280B) mediates pro-survival and pro-growth functions in prostate cancer. However, in gastric cancer, its clinical significance remains poorly characterized. In the present study, the expression levels of ZNF280B in 60 patients with gastric cancer were examined using immunohistochemistry. The association between ZNF280B expression and clinicopathological features was assessed. Positive ZNF280B staining was demonstrated for 38 (63.3%) samples out of 60 gastric cancer cases in immunohistochemical analysis. ZNF280B expression was significantly associated with tumor size (P=0.017) and TNM stage (P=0.001). Furthermore, the proliferation index in the positive ZNF280B expression group was significantly higher (38.8±6.2) compared with that of the negative ZNF280B expression group (16.9±8.9; P<0.01). These results suggest that ZNF280B expression may be associated with the proliferation of gastric cancer cells. The role of ZNF280B in the growth of gastric cancer cells (MGC-803) was also investigated in vitro and in vivo by enhancing the expression of ZNF280B. A colony formation assay indicated that the number of colonies in the MGC-803 cells with enhanced ZNF280B (146±5.8) was significantly higher than that of the MGC-803 control group (97±5.1) and the negative control group (101±6.5; P<0.05). An MTT assay demonstrated that ZNF280B significantly promoted the proliferation of MGC-803 cells at days 3 and 4 (P<0.05). It was observed that the overexpression of ZNF280B may promote the growth of gastric cancer in vivo in xenograft studies. These findings indicate that ZNF280B may be a novel therapeutic target for gastric cancer.

[1]  K. Ocorr,et al.  ZNF307, a novel zinc finger gene suppresses p53 and p21 pathway. , 2007, Biochemical and biophysical research communications.

[2]  Yong Li,et al.  Role of RNA-interference-induced zinc finger protein 139 suppression in gastric cancer cell sensitivity to chemotherapeutic agents. , 2015, Oncology letters.

[3]  Junwu Zhang,et al.  Identification of the Trans-Activation Domain and the Nuclear Location Signals of Human Zinc Finger Protein HZF1 (ZNF16) , 2010, Molecular biotechnology.

[4]  Jiong Hu,et al.  Inhibitory effect of RNA-mediated knockdown of zinc finger protein 91 pseudogene on pancreatic cancer cell growth and invasion , 2016, Oncology letters.

[5]  G. Mills,et al.  ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer. , 2011, Cancer research.

[6]  Douglas D Boyd,et al.  The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression. , 2008, Cancer research.

[7]  K. Coombes,et al.  Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene. , 2009, Leukemia research.

[8]  Daria A. Gaykalova,et al.  Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients , 2015, PloS one.

[9]  Z. Li,et al.  Comparative proteomics analysis of human osteosarcomas and benign tumor of bone. , 2010, Cancer genetics and cytogenetics.

[10]  Jun Zhou,et al.  Zinc Finger 280B Regulates sGCα1 and p53 in Prostate Cancer Cells , 2013, PloS one.

[11]  K. Sakaguchi,et al.  Tetramer formation of tumor suppressor protein p53: Structure, function, and applications , 2016, Biopolymers.

[12]  Lin Fang,et al.  ZNF703 acts as an oncogene that promotes progression in gastric cancer. , 2014, Oncology reports.

[13]  J. Haerting,et al.  Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  W. Sellers,et al.  Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. , 2002, Cancer research.

[15]  Peggy J. Farnham,et al.  ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells , 2010, Oncogene.

[16]  T. Iwakuma,et al.  Targeting Oncogenic Mutant p53 for Cancer Therapy , 2015, Front. Oncol..

[17]  Zinc finger proteins in cancer progression , 2016, Journal of Biomedical Science.

[18]  Sandra L. Harper,et al.  Biochemical Analysis of the Kruppel-associated Box (KRAB) Transcriptional Repression Domain , 2000, The Journal of Biological Chemistry.

[19]  Jin Jiang,et al.  Zinc finger protein X-linked is overexpressed in colorectal cancer and is associated with poor prognosis. , 2015, Oncology letters.

[20]  Gang Liu,et al.  Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer , 2016, OncoTargets and therapy.

[21]  Yixin Chen,et al.  A Risk Score System to Preoperatively Predict TNM Stages in Gastric Cancer , 2010, American journal of clinical oncology.

[22]  Huanjie Shao,et al.  Aberrant alternative splicing of human zinc finger gene ZNF268 in human hematological malignancy. , 2008, Oncology reports.